Literature DB >> 2959679

Dysfunction of suppressor T cells in thyroid glands from patients with Graves' disease.

Y Ueki1, K Eguchi, T Fukuda, T Otsubo, Y Kawabe, C Shimomura, M Matsunaga, H Tezuka, N Ishikawa, K Ito.   

Abstract

To investigate the suppressor function of intrathyroidal (TG) T cells in Graves' disease, the percentage of suppressor T cell subsets and the suppressor function of TG and peripheral blood (PB) lymphocytes in Graves' disease were compared by determining the in vitro production of immunoglobulin G (IgG) in reconstituted mixtures of separated B, CD4+ (helper/suppressor-inducer T), and CD8+ (suppressor/cytotoxic T) cells. TG lymphocytes were obtained by gradient centrifugation of the supernatants of minced thyroid tissues. T Cells were separated by E-rosette formation, and CD4+ and CD8+ cell-rich populations were separated by a panning method using monoclonal anti-CD8 antibody. Mixtures of 5 X 10(4) B (PB1 or TG) cells, 2 X 10(4) CD4+ (PB or TG) cells, and 5 X 10(3) macrophages (PB or TG) were cultured with various numbers of CD8+ (PB) or CD8+ (TG) cells for 7 days with pokeweed mitogen, and IgG synthesis was determined by solid phase RIA. T cell subpopulations were quantitated by a direct immunofluorescence method using monoclonal anti-CD3, anti-CD4, and anti-CD8 antibodies. There was no difference in the percentages of CD8+ cells among total T cells between thyroid glands and peripheral blood from Graves' disease patients [mean PB, 39.8 +/- 9.8% (+/- SD); TG, 42.5 +/- 13.8%; n = 10]. IgG production by mixtures of B and CD4+ cells isolated from peripheral blood was not different from that by cells isolated from thyroid glands [mean PB, 1635 +/- 248 (+/- SE) ng/mL; TG, 1081 +/- 128 ng/mL; n = 19; P = NS]. The nonspecific suppressor activity of thyroid gland CD8+ cells was less than that of CD8+ (PB) cells [percent suppression of IgG production by mixtures of B (PB) and CD4+ (PB) cells, 12.5% vs. 57.0% (P less than 0.01); by mixtures of B (TG) and CD4+ (TG) cells, 5.8% vs. 38.9% (P less than 0.01)]. The suppressor-inducer function of CD4+ (TG) cells was also decreased compared with that of CD4+ (PB) cells. These results suggest that the impairment of suppressor cell activity may lead to excessive production of autoantibody in thyroid glands from patients with Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2959679     DOI: 10.1210/jcem-65-5-922

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.

Authors:  R Wilson; J H McKillop; C Pearson; A K Burnett; I Gunn; A M McNicol; J A Thomson
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

2.  HTLV-I associated arthritis: characteristics of an HTLV-I virus infected T cell line from synovial fluid.

Authors:  K Eguchi; T Nakamura; M Mine; H Ida; A Kawakami; K Migita; K Nagasato; A Kurata; T Fukuda; S Nagataki
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

3.  Study of induction of activation of human peripheral blood mononuclear cells with a non-activating form of anti-CD3 MoAb in autoimmune thyroid disease (AITD).

Authors:  E Resetkova; G Arreaza; N Yoshikawa; T Morita; H Kim; P Carayon; R Volpé
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

4.  Reduced activation of suppressor T lymphocytes by specific antigens in autoimmune thyroid disease.

Authors:  N Yoshikawa; T Morita; E Resetkova; G Arreanza; P Carayon; R Volpé
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

5.  Serum cytokines in patients with rheumatoid arthritis. Correlation of interferon gamma and tumor necrosis factor alpha with the characteristics of peripheral blood mononuclear cells.

Authors:  S Sakito; Y Ueki; K Eguchi; Y Kawabe; S Nagataki
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

6.  Lymphocyte subsets in hemodialysis patients treated with recombinant human erythropoietin.

Authors:  Y Ueki; M Nagata; S Miyake; Y Tominaga
Journal:  J Clin Immunol       Date:  1993-07       Impact factor: 8.317

7.  Increment of CD8S6F1 cells in synovial fluid from patients with rheumatoid arthritis.

Authors:  Y Ueki; K Eguchi; S Miyake; S Nagataki; Y Tominaga
Journal:  Ann Rheum Dis       Date:  1994-12       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.